Table 6 Association of SOAT1 expression with the characteristic of HCC patients
From: Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma
Low expression | High expression | P value† | OR | CI (95%) | |
|---|---|---|---|---|---|
rs10753191 | |||||
CC | 8 | 9 | Ref. | 1 | |
CT | 8 | 9 | 1 | 1 | 0.260–3.845 |
TT | 3 | 5 | 1 | 1.481 | 0.265–8.267 |
Dominant model | 1 | 1.131 | 0.328–3.898 | ||
Recessive model | 0.709 | 0.675 | 0.139–3.283 | ||
rs13306731 | |||||
AA | 9 | 9 | Ref. | 1 | |
AG | 7 | 11 | 1 | 1 | 0.158–6346 |
GG | 3 | 3 | 0.738 | 1.571 | 0.418–5.903 |
Dominant model | 0.756 | 0.714 | 0.209–2.443 | ||
Recessive model | 1 | 0.800 | 0.142–4.513 | ||
Haplotype | |||||
CCA | 24 (63.16%) | 27 (58.70%) | Ref. | / | |
TGA | 1 (2.63%) | 2 (4.35%) | 1 | 1.778 | 0.151–20.863 |
TGG | 13 (34.21%) | 17 (36.96%) | 0.819 | 1.162 | 0.469–2.881 |
Stage | |||||
0-B | 12 | 15 | Ref. | / | |
C-D | 7 | 8 | 1 | 1.094 | 0.308–3.883 |